Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium-Reference-Cited by-同舟云学术

Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium

Published:2015-07-23 Issue:12 Volume:1 Page:593-603
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Machado Diana¹,Cannalire Rolando²,Santos Costa Sofia¹,Manfroni Giuseppe²,Tabarrini Oriana²,Cecchetti Violetta²,Couto Isabel¹,Viveiros Miguel¹,Sabatini Stefano²

Affiliation:

1. Grupo de Micobactérias, Unidade de Microbiologia Médica, Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT, UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal

2. Department of Pharmaceutical Sciences, Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy

Funder

Funda??o para a Ci?ncia e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.5b00052

Reference52 articles.

1. World Health Organization (WHO). ( (2015) Global tuberculosis report 2013, Geneva, Switzerland,http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1(accessed March 20, 2015); ISBN: 978 92 4 156465 6.

2. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011

3. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease

4. Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections;Expert Review of Anti-infective Therapy;2024-08-21

2. Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry;Bioorganic & Medicinal Chemistry;2024-07

3. Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate;Archiv der Pharmazie;2024-06-26

4. Nitric oxide-releasing prodrug for the treatment of complex Mycobacterium abscessus infections;Antimicrobial Agents and Chemotherapy;2024-02-07

5. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges;Expert Review of Respiratory Medicine;2023-11-02